key: cord-0989773-qwncnag7
authors: Lippi, Giuseppe; Sanchis‐Gomar, Fabian; Henry, Brandon M.
title: Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection
date: 2021-02-08
journal: Int J Lab Hematol
DOI: 10.1111/ijlh.13482
sha: 9a08c1b05e1171e3597a16fafa5d88065222b8c9
doc_id: 989773
cord_uid: qwncnag7

nan

The ongoing and relentless worldwide diffusion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is jeopardizing the response capacity of most healthcare systems. This includes the capability to provide diagnostic tests to all people who need them for purposes of clinical diagnosis, contact tracing, and even for monitoring the progression of coronavirus disease 2019 (COVID-19). 1 To this end, the availability of additional tests or algorithms which may anticipate the result of SARS-CoV-2 molecular testing would be welcomed for guiding the diagnostic process, thus preventing unnecessary waste of reagents and avoiding to further overwhelm already burdened clinical laboratories.

Convincing evidence has been provided that the monocyte distribution width (MDW), a simple laboratory parameter that can be automatically calculated and reported by specific hematological analyzers manufactured by Beckman Coulter (Beckman Coulter) along with the complete blood count, reflects some changes in monocyte biology (especially size) that are highly predictive of critical acute infections and/or viral sepsis. 2, 3 Interestingly, significant differences in morphology and function of monocytes have been recently observed between COVID-19 patients and healthy individuals. 4 Therefore, in this article, we aim to provide a pooled analysis of studies that have addressed the potential clinical utility of MDW for predicting SARS-CoV-2 infection at hospital admission.

An electronic search was carried out in Medline (PubMed interface), Scopus, and Web of Science, with the keywords "monocyte distribution width" OR "MDW" AND "coronavirus disease 2019" OR "COVID-19" OR "SARS-CoV-2" without date (ie, up to December 5, 2020) and language restrictions, according to the protocol based on the transparent reporting of systematic reviews and meta-analysis (PRISMA) (Appendix S1). The title, abstract, and full text of all articles that could be identified with these search criteria were system- (Table 1) . One study compared MDW in COVID-19 positive patients vs COVID-19 negative controls, 7 one study compared MDW in COVID-19 symptomatic and paucisymptomatic patients presenting to the emergency department, 6 and one study compared MDW in those with COVID-19 as opposed to upper respiratory tract infections. 5 In all three studies, the cutoff was set at a similar threshold (≥20 in two studies and ≥20.1 in the third, respectively), and MDW values were higher in patients with SARS-CoV-2 infection than those without, as shown in Figure 1 . Despite a relevant heterogeneity (I 2 , 91%), the pooled analysis revealed that the MDW value was 14.4% higher in patients with SARS-CoV-2 infection than in those without (WMD, 3.95; 95% CI, 1.41-6.49) ( Figure 1 ).

Despite the limited numbers of studies available so far and their lack of uniformity, the results of this pooled analysis suggest that MDW at hospital admission is higher in subjects with active SARS-CoV-2 infection than in those without. As reported by Lin et al, 5 MDW was significantly elevated in patients with COVID-19, even in comparison with those with upper respiratory tract infections. This is not an unexpected finding, as monocytes biology appears considerably perturbed in patients with SARS-CoV-2 infection. 8 This may be due to direct cytopathic effect of SARS-CoV-2 on this cell lineage, as well as to direct or indirect cell activation by circulating cytokines and/or immunocomplexes. 9 Regardless of the underlying mechanisms, further studies should be planned to define the role of MDW within diagnostic algorithms for rationing SARS-CoV-2 diagnostics and for predicting disease progression and complications, especially the hyperinflammatory syndrome, which frequently characterize severe or critical COVID-19 illness. 10 

Government faces criticism over pound500m plan to pilot mass testing

Improved early detection of sepsis in the ED with a novel monocyte distribution width biomarker

Monocyte distribution width: a novel indicator of sepsis-2 and sepsis-3 in high-risk emergency department patients

Rad F COVID-19 and hematology findings based on the current evidences: a puzzle with many missing pieces

Clinical impact of monocyte distribution width and neutrophil-to-lymphocyte ratio for distinguishing COVID-19 and influenza from other upper respiratory tract infections: a pilot study

Elevated monocyte distribution width in COVID-19 patients: the contribution of the novel sepsis indicator

Monocyte volumetric parameters and lymph index are increased in SARS-CoV-2 infection

COVID-19 and the clinical hematology laboratory

Monocyte activation in systemic Covid-19 infection: assay and rationale

Lippi G Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: a novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis

Additional supporting information may be found online in the Supporting Information section.